1例莫西沙星致肺炎患者心力衰竭临床治疗的药学监护  

Pharmaceutical Care for Clinical Medication in A Pneumonia Patient with Heart Failure Caused by Moxifloxacin

作　　者：钱元霞 汤静[2] 

机构地区：[1]镇江市中西医结合医院,江苏镇江212000 [2]上海交通大学附属第一人民医院,上海201620

出　　处：《抗感染药学》2017年第2期316-318,共3页Anti-infection Pharmacy

摘　　要：目的:分析莫西沙星致肺炎患者心力衰竭临床治疗的药学监护过程,探讨临床药师在不良反应监测及处理中的作用。方法:临床药师参与患者全程用药监护过程,通过患者的临床表现、病史、相关检查等方面,分析不良反应发生的可能药物及原因,提供用药建议。结果:临床药师建议被采纳,在一定程度上保证了用药安全。结论:临床药师需加强学习与交流,不断积累经验,参与临床合理用药,减少不良反应的发生,为患者提供全程用药监护发挥了作用。Objective： To analyze of the process of the pharmaceutical care for clinical medication in a pneumonia patient with heart failure caused by moxifloxacin, and to explore the role of clinical pharmacists in the adverse drug re- actions monitoring and treatment. Methods： Clinical pharmacists participated in the process of entire medical care, through the patient＇s clinical manifestations, medical history, and related inspection they, analyzed the possible drug and reason of adverse reaction, and provided advice. Results： Clinical pharmacists＇ opinions were adopted, ensuring the medication safety to a certain extent. Conclusion： Clinical pharmacists should strengthen learning and communication, accumulate experience, participate in clinical rational drug use, reduce the occurrence of adverse reactions, and play an important role in providing patients with the whole monitoring of medicine.

关 键 词：莫西沙星 心力衰竭 药物不良反应 用药监护 

分 类 号：R969.3[医药卫生—药理学]